I am very proud to be part of the amazing team of researchers, scientists and clinicians who are all co-authors of the important research publication just released in Nature Medicine. The paper documents changes in my brain tumour & blood before and after I received neoadjuvant systemic combination immunotherapy treatment, which occurred in 2023. Everyone involved, including lead authors Georgina Long and Helen Rizos, used their expertise, knowledge and creative intellect to generate this important data just released. Whilst the paper deals with the data from just one patient (me), ultimately a clinical trial of a large group of patients needs to be conducted to determine whether or not neoadjuvant (pretreatment) combination immunotherapy is clinically effective in (a subgroup of) brain cancer patients. I hope such a trial begins in the not too distant future. Congratulations to everyone who has contributed to this research. What a fantastic achievement! But this is only the beginning & much more research is required to improve treatment and outcomes and ultimately save lives. @SydneyLHD @NthSydHealth @Sydney_Uni @COBLH #glioblastoma
